Evotec OAI AG, Boehringer Ingelheim deal

Under a three-year deal, EVT and its Evotec Neurosciences subsidiary partnered with Boehringer to jointly identify and develop small molecule therapeutics against GPCRs, with an initial focus on CNS d...